Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation
Open Access
- 9 July 2026
- journal article
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
Abstract
Cardiology consultants can find the latest news & information about cardiovascular disease & cardiology conferences by going to Radcliffe cardiology’s website.Keywords
This publication has 6 references indexed in Scilit:
- Therapeutic Drug Monitoring of Direct Oral Anticoagulants and Its Association with Clinical Outcomes: A Systematic Review and Meta-AnalysisPharmaceuticals, 2026
- Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation: Current Status and Future Perspectives in Malaysia.2025
- Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillationEP Europace, 2021
- Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulantsJournal of Thrombosis and Haemostasis, 2019
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral AnticoagulantsJACC, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014